“Demystifying the results obtained through the use of SGLT-2 inhibitor drugs, used by patients at the Reference Center for Hypertension and Diabetes Rio Verde - Goiás”, RSD, vol. 12, no. 12, p. e76121243964, Nov. 2023, doi: 10.33448/rsd-v12i12.43964.